Characterization_NN
of_IN
5_CD
'_POS
end_NN
of_IN
human_JJ
thromboxane_NN
receptor_NN
gene_NN
._.

Organizational_JJ
analysis_NN
and_CC
mapping_NN
of_IN
protein_NN
kinase_NN
C_NN
--_:
responsive_JJ
elements_NNS
regulating_VBG
expression_NN
in_IN
platelets_NNS
._.

Platelet_NN
thromboxane_NN
receptors_NNS
are_VBP
acutely_RB
and_CC
reversibly_RB
upregulated_VBN
after_IN
acute_JJ
myocardial_JJ
infarction_NN
._.

To_TO
determine_VB
if_IN
platelet_NN
thromboxane_NN
receptors_NNS
are_VBP
under_IN
transcriptional_JJ
control_NN
,_,
we_PRP
isolated_VBD
and_CC
characterized_VBD
human_JJ
genomic_JJ
DNA_NN
clones_NNS
containing_VBG
the_DT
5_CD
'_NN
flanking_JJ
region_NN
of_IN
the_DT
thromboxane_NN
receptor_NN
gene_NN
._.

The_DT
exon-intron_JJ
structure_NN
of_IN
the_DT
5_CD
'_POS
portion_NN
of_IN
the_DT
thromboxane_NN
receptor_NN
gene_NN
was_VBD
determined_VBN
initially_RB
by_IN
comparing_VBG
the_DT
nucleotide_JJ
sequence_NN
of_IN
the_DT
5_CD
'_``
flanking_JJ
genomic_JJ
clone_NN
with_IN
that_DT
of_IN
a_DT
novel_JJ
human_JJ
uterine_JJ
thromboxane_NN
receptor_NN
cDNA_NN
that_WDT
extended_VBD
the_DT
mRNA_NN
141_CD
bp_NN
further_RBR
upstream_RB
than_IN
the_DT
previously_RB
identified_VBN
human_JJ
placental_JJ
cDNA_NN
._.

A_DT
major_JJ
transcription_NN
initiation_NN
site_NN
was_VBD
located_JJ
in_IN
three_CD
human_JJ
tissues_NNS
approximately_RB
560_CD
bp_NN
upstream_RB
from_IN
the_DT
translation_NN
initiation_NN
codon_NN
and_CC
380_CD
bp_NN
upstream_RB
from_IN
any_DT
previously_RB
identified_VBN
transcription_NN
initiation_NN
site_NN
._.

The_DT
thromboxane_NN
receptor_NN
gene_NN
has_VBZ
neither_CC
a_DT
TATA_NN
nor_CC
a_DT
CAAT_NN
consensus_NN
site_NN
._.

Promoter_NN
function_NN
of_IN
the_DT
5_CD
'_``
flanking_JJ
region_NN
of_IN
the_DT
thromboxane_NN
receptor_NN
gene_NN
was_VBD
evaluated_VBN
by_IN
transfection_NN
of_IN
thromboxane_NN
receptor_NN
gene_NN
promoter\/chloramphenicol_NN
acetyltransferase_NN
-LRB-_-LRB-
CAT_NN
-RRB-_-RRB-
chimera_NN
plasmids_NNS
into_IN
platelet-like_JJ
K562_NN
cells_NNS
._.

Thromboxane_NN
receptor_NN
promoter_NN
activity_NN
,_,
as_IN
assessed_VBN
by_IN
CAT_NN
expression_NN
,_,
was_VBD
relatively_RB
weak_JJ
but_CC
was_VBD
significantly_RB
enhanced_VBN
by_IN
phorbol_NN
ester_NN
treatment_NN
._.

Functional_JJ
analysis_NN
of_IN
5_CD
'_``
deletion_NN
constructs_NNS
in_IN
transfected_JJ
K562_NN
cells_NNS
and_CC
gel_NN
mobility_NN
shift_NN
localized_JJ
the_DT
major_JJ
phorbol_NN
ester-responsive_JJ
motifs_NNS
in_IN
the_DT
thromboxane_NN
receptor_NN
gene_NN
promoter_NN
to_TO
a_DT
cluster_NN
of_IN
activator_NN
protein-2_NN
-LRB-_-LRB-
AP-2_NN
-RRB-_-RRB-
binding_NN
consensus_NN
sites_NNS
located_JJ
approximately_RB
1.8_CD
kb_NN
5_CD
'_''
from_IN
the_DT
transcription_NN
initiation_NN
site_NN
._.

These_DT
studies_NNS
are_VBP
the_DT
first_JJ
to_TO
determine_VB
the_DT
structure_NN
and_CC
organization_NN
of_IN
the_DT
5_CD
'_POS
end_NN
of_IN
the_DT
thromboxane_NN
receptor_NN
gene_NN
and_CC
demonstrate_VBP
that_IN
thromboxane_NN
receptor_NN
gene_NN
expression_NN
can_MD
be_VB
regulated_VBN
by_IN
activation_NN
of_IN
protein_NN
kinase_NN
C_NN
via_IN
induction_NN
of_IN
an_DT
AP-2-like_JJ
nuclear_JJ
factor_NN
binding_NN
to_TO
upstream_JJ
promoter_NN
elements_NNS
._.

These_DT
findings_NNS
strongly_RB
suggest_VBP
that_IN
the_DT
mechanism_NN
for_IN
previously_RB
described_VBN
upregulation_NN
of_IN
platelet_NN
thromboxane_NN
receptors_NNS
after_IN
acute_JJ
myocardial_JJ
infarction_NN
is_VBZ
increased_VBN
thromboxane_NN
receptor_NN
gene_NN
transcription_NN
in_IN
platelet-progenitor_JJ
cells_NNS
._.

